Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer

Key Points • Breast tumor–produced coagulation FVII induces EMT and liver metastasis via endothelial protein C receptor.• Blood-borne FVII antagonizes the effects of tumor-expressed FVII by activating the TF-PAR2 axis.

[1]  Qingyu Wu,et al.  Hepsin: a multifunctional transmembrane serine protease in pathobiology , 2020, The FEBS journal.

[2]  Sylvia E. Le Dévédec,et al.  The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice , 2019, Journal of thrombosis and haemostasis : JTH.

[3]  F. Padilla,et al.  Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer , 2018, Theranostics.

[4]  W. Ruf,et al.  Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling. , 2018, Blood.

[5]  M. Hollenberg,et al.  Transforming Growth Factor-β1/Activin Receptor-like Kinase 5-Mediated Cell Migration is Dependent on the Protein Proteinase-Activated Receptor 2 but not on Proteinase-Activated Receptor 2-Stimulated Gq-Calcium Signaling , 2017, Molecular Pharmacology.

[6]  A. Gruber,et al.  Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex. , 2017, Blood.

[7]  G. Landberg,et al.  Tissue Factor promotes breast cancer stem cell activity in vitro , 2016, Oncotarget.

[8]  H. He,et al.  SOX9 drives WNT pathway activation in prostate cancer. , 2016, The Journal of clinical investigation.

[9]  Chi-Chih Wang,et al.  Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling , 2015, Cell Death Discovery.

[10]  H. Versteeg,et al.  Orthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth. , 2015, Journal of visualized experiments : JoVE.

[11]  A. Naderi.  Coagulation factor VII is regulated by androgen receptor in breast cancer. , 2015, Experimental cell research.

[12]  P. Reitsma,et al.  Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner , 2013, Proceedings of the National Academy of Sciences.

[13]  C. Esmon,et al.  Endothelial Protein C Receptor Function in Murine and Human Breast Cancer Development , 2013, PloS one.

[14]  Wenjun Guo,et al.  Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.

[15]  Y. Miyagi,et al.  HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic conditions in ovarian cancer cells , 2012, Nucleic acids research.

[16]  P. Reitsma,et al.  The relationship between tissue factor and cancer progression: insights from bench and bedside. , 2012, Blood.

[17]  H. Putter,et al.  COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients , 2011, Breast Cancer Research and Treatment.

[18]  Yinmo Yang,et al.  Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis. , 2010, Chinese Medical Journal.

[19]  J. Rak,et al.  Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. , 2010, Blood.

[20]  Y. Miyagi,et al.  Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells , 2009, British Journal of Cancer.

[21]  A. Guha,et al.  Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. , 2008, Cancer research.

[22]  M. Steinhoff,et al.  Proteinase-activated receptor-2 (PAR2): a tumor suppressor in skin carcinogenesis. , 2007, The Journal of investigative dermatology.

[23]  K. Fukudome,et al.  Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity , 2007, Journal of thrombosis and haemostasis : JTH.

[24]  Zhiwei Hu,et al.  Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. , 2007, Blood.

[25]  Y. Miyagi,et al.  Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. , 2006, Cancer research.

[26]  H. Versteeg,et al.  Disulfide isomerization switches tissue factor from coagulation to cell signaling , 2006, Proceedings of the National Academy of Sciences.

[27]  T. Hembrough,et al.  Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. , 2003, Cancer research.

[28]  M. Peppelenbosch,et al.  The Pleiotropic Effects of Tissue Factor: a Possible Role for Factor VIIa-induced Intracellular Signalling? , 2001, Thrombosis and Haemostasis.

[29]  S. Nakamura,et al.  Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration , 2000, British Journal of Cancer.

[30]  C. Esmon,et al.  The Endothelial Cell Protein C Receptor , 2000, Thrombosis and Haemostasis.

[31]  M. Peppelenbosch,et al.  The role of phosphatidylinositide‐3‐kinase in basal mitogen‐activated protein kinase activity and cell survival , 2000, FEBS letters.

[32]  C. Esmon,et al.  Endothelial Protein C Receptor , 1999, Thrombosis and Haemostasis.

[33]  P. Carmeliet,et al.  Mice lacking factor VII develop normally but suffer fatal perinatal bleeding , 1997, Nature.

[34]  Y. Takada,et al.  Hemostasis, Thrombosis, and Vascular Biology: Inhibition of tissue factor signaling suppresses tumor growth , 2014 .

[35]  E. Persson,et al.  Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study. , 2005, Thrombosis research.